| Style | Citing Format |
|---|---|
| MLA | Yaghoobian R, et al.. "Caffeine Drug Interactions and Its Clinical Implication After Acute Coronary Syndrome: A Literature Review." Critical Pathways in Cardiology, vol. 22, no. 3, 2023, pp. 95-99. |
| APA | Yaghoobian R, Sharifi M, Rezaee M, Vahidi H, Salehi N, Hosseini K (2023). Caffeine Drug Interactions and Its Clinical Implication After Acute Coronary Syndrome: A Literature Review. Critical Pathways in Cardiology, 22(3), 95-99. |
| Chicago | Yaghoobian R, Sharifi M, Rezaee M, Vahidi H, Salehi N, Hosseini K. "Caffeine Drug Interactions and Its Clinical Implication After Acute Coronary Syndrome: A Literature Review." Critical Pathways in Cardiology 22, no. 3 (2023): 95-99. |
| Harvard | Yaghoobian R et al. (2023) 'Caffeine Drug Interactions and Its Clinical Implication After Acute Coronary Syndrome: A Literature Review', Critical Pathways in Cardiology, 22(3), pp. 95-99. |
| Vancouver | Yaghoobian R, Sharifi M, Rezaee M, Vahidi H, Salehi N, Hosseini K. Caffeine Drug Interactions and Its Clinical Implication After Acute Coronary Syndrome: A Literature Review. Critical Pathways in Cardiology. 2023;22(3):95-99. |
| BibTex | @article{ author = {Yaghoobian R and Sharifi M and Rezaee M and Vahidi H and Salehi N and Hosseini K}, title = {Caffeine Drug Interactions and Its Clinical Implication After Acute Coronary Syndrome: A Literature Review}, journal = {Critical Pathways in Cardiology}, volume = {22}, number = {3}, pages = {95-99}, year = {2023} } |
| RIS | TY - JOUR AU - Yaghoobian R AU - Sharifi M AU - Rezaee M AU - Vahidi H AU - Salehi N AU - Hosseini K TI - Caffeine Drug Interactions and Its Clinical Implication After Acute Coronary Syndrome: A Literature Review JO - Critical Pathways in Cardiology VL - 22 IS - 3 SP - 95 EP - 99 PY - 2023 ER - |